type |
Ex - Dividend Date |
payment date |
value |
|---|---|---|---|
| Dividends | 10/17/2023 | 10/18/2023 | 0.04870000 |
| Dividends | 12/30/2021 | 12/31/2021 | 3.03143000 |
| Dividends | 12/31/2020 | 01/04/2021 | 0.15462000 |
| Dividends | 12/24/2019 | 12/26/2019 | 0.04025000 |
| Company name | Ticker | Asset type | Sector | Market cap | % in ETF |
|---|---|---|---|---|---|
| RACA | Stock | Financial | US$ 179.12 M | 2,39% | |
| MRTX | Stock | Healthcare | US$ 4.12 B | 2,30% | |
|
Rain Oncology Inc
|
RAIN_old2 | Stock | Industrials | US$ 27.83 M | 1,70% |
| HCM | Stock | Healthcare | US$ 1.84 B | 1,57% | |
Nuvalent Inc
|
NUVL | Stock | Healthcare | US$ 9.81 B | 1,47% |
| MRSN | Stock | Healthcare | US$ 145.36 M | 1,46% | |
|
ZYMEWORKS DL-00001
|
ZA8 | Stock | Healthcare | US$ 1.77 B | 1,44% |
| YMAB | Stock | Healthcare | US$ 391.22 M | 1,44% | |
| MGNX | Stock | Healthcare | US$ 280.28 M | 1,42% | |
| SGEN | Stock | Healthcare | US$ 43.15 B | 1,41% | |
Arcellx Inc
|
ACLX | Stock | Healthcare | US$ 6.73 B | 1,38% |
|
EQRx Inc
|
EQRX | Stock | Healthcare | US$ 1.14 B | 1,37% |
| LEGN | Stock | Healthcare | US$ 4.23 B | 1,37% | |
| SMMT | Stock | Healthcare | US$ 13.67 B | 1,35% | |
| REGN | Stock | Healthcare | US$ 86.84 B | 1,35% | |
|
EXAI
|
EXAI_old | Stock | Healthcare | US$ 2.59 B | 1,34% |
| VOR | Stock | Healthcare | US$ 1.31 B | 1,33% | |
| EXEL | Stock | Healthcare | US$ 14.62 B | 1,32% | |
| BMY | Stock | Healthcare | US$ 136.49 B | 1,31% | |
| MRK | Stock | Healthcare | US$ 370.89 B | 1,31% | |
|
TYRA
|
TYRA_old | Stock | Healthcare | US$ 903.02 M | 1,31% |
|
Compass Therapeutics Inc.
|
CMPX_old | Stock | Other | - | 1,27% |
2Seventy Bio Inc
|
TSVT | Stock | Healthcare | US$ 266.14 M | 1,27% |
Lyell Immunopharma Inc
|
LYEL | Stock | Healthcare | US$ 350.91 M | 1,25% |
| BPMC | Stock | Healthcare | US$ 8.37 B | 1,25% | |
| FATE | Stock | Healthcare | US$ 289.97 M | 1,24% | |
| IMGN | Stock | Healthcare | US$ 8.72 B | 1,23% | |
| NUVB | Stock | Healthcare | US$ 2.38 B | 1,23% | |
| IMCR | Stock | Healthcare | US$ 1.93 B | 1,22% | |
| AURA | Stock | Healthcare | US$ 764.30 M | 1,22% | |
| AUTL | Stock | Healthcare | US$ 596.20 M | 1,22% | |
Genelux Corporation Common Stock
|
GNLX | Stock | Healthcare | US$ 110.40 M | 1,22% |
| BCTG | Stock | Financial | US$ 218.05 M | 1,21% | |
| RVMD | Stock | Healthcare | US$ 45.01 B | 1,20% | |
| XNCR | Stock | Healthcare | US$ 1.98 B | 1,20% | |
| ACET | Stock | Healthcare | US$ 89.78 M | 1,20% | |
| CGEM | Stock | Healthcare | US$ 1.34 B | 1,20% | |
| KPTI | Stock | Healthcare | US$ 40.60 M | 1,20% | |
| IDYA | Stock | Healthcare | US$ 3.85 B | 1,18% | |
Erasca Inc
|
ERAS | Stock | Healthcare | US$ 5.69 B | 1,18% |
| KURA | Stock | Healthcare | US$ 1.17 B | 1,14% | |
| SWTX | Stock | Healthcare | US$ 3.54 B | 1,14% | |
| MRUS | Stock | Healthcare | US$ 6.83 B | 1,14% | |
| REPL | Stock | Healthcare | US$ 1.42 B | 1,13% | |
| GERN | Stock | Healthcare | US$ 1.01 B | 1,13% | |
| BCYC | Stock | Healthcare | US$ 300.97 M | 1,12% | |
| MOR | Stock | Healthcare | US$ 2.86 B | 1,12% | |
| STRO | Stock | Healthcare | US$ 332.78 M | 1,11% | |
| DNA | Stock | Healthcare | US$ 468.01 M | 1,11% | |
|
Theseus Pharmaceuticals Inc
|
THRX | Stock | Healthcare | US$ 181.28 M | 1,10% |
| BNTX | Stock | Healthcare | US$ 26.06 B | 1,10% | |
Enliven Therapeutics Inc.
|
ELVN | Stock | Healthcare | US$ 4.35 B | 1,07% |
| GMAB | Stock | Healthcare | US$ 133.07 B | 1,07% | |
Arcus Biosciences Inc
|
RCUS | Stock | Healthcare | US$ 3.73 B | 1,07% |
| IPHA | Stock | Healthcare | US$ 232.34 M | 1,06% | |
| ALLO | Stock | Healthcare | US$ 680.62 M | 1,05% | |
| ZNTL | Stock | Healthcare | US$ 377.74 M | 1,05% | |
| DCPH | Stock | Healthcare | US$ 2.21 B | 1,04% | |
| PRLD | Stock | Healthcare | US$ 418.97 M | 1,03% | |
Inhibrx Inc
|
INBX_old | Stock | Healthcare | US$ 220.18 M | 1,02% |
| IMRX | Stock | Healthcare | US$ 326.07 M | 1,00% | |
| NGM | Stock | Healthcare | US$ 128.53 M | 0,99% | |
| RLAY | Stock | Healthcare | US$ 4.06 B | 0,99% | |
| ITOS | Stock | Healthcare | US$ 448.68 M | 0,99% | |
| NK | Stock | Healthcare | US$ 3.55 B | 0,99% | |
| IMTX | Stock | Healthcare | US$ 1.46 B | 0,98% | |
Biomea Fusion Inc
|
BMEA | Stock | Healthcare | US$ 138.09 M | 0,98% |
| PGEN | Stock | Healthcare | US$ 2.54 B | 0,97% | |
| RXRX | Stock | Healthcare | US$ 1.84 B | 0,95% | |
Day One Biopharmaceuticals Inc
|
DAWN | Stock | Healthcare | US$ 2.22 B | 0,95% |
Janux Therapeutics Inc
|
JANX | Stock | Healthcare | US$ 1.21 B | 0,93% |
| AGEN | Stock | Healthcare | US$ 370.88 M | 0,93% | |
| CRBU | Stock | Healthcare | US$ 168.32 M | 0,91% | |
| SDGR | Stock | Healthcare | US$ 1.50 B | 0,91% | |
| SNDX | Stock | Healthcare | US$ 1.85 B | 0,91% | |
| KYMR | Stock | Healthcare | US$ 9.65 B | 0,87% | |
| IOVA | Stock | Healthcare | US$ 3.94 B | 0,86% | |
| ARVN | Stock | Healthcare | US$ 613.98 M | 0,83% | |
| IGMS | Stock | Healthcare | US$ 76.57 M | 0,81% | |
| RAPT | Stock | Healthcare | US$ 1.68 B | 0,80% | |
| NRIX | Stock | Healthcare | US$ 2.71 B | 0,74% | |
| ACRV | Stock | Healthcare | US$ 91.28 M | 0,72% | |
Monte Rosa Therapeutics Inc
|
GLUE | Stock | Healthcare | US$ 1.23 B | 0,62% |
| FHTX | Stock | Healthcare | US$ 289.21 M | 0,62% | |
| RPTX | Stock | Healthcare | US$ 114.24 M | 0,58% |
Average Investor10 user rating
4.0
(0 people)
ETF Series Solutions - Loncar China BioPharma ETF (United States) is an exchange-traded fund (ETF), with assets under management totaling $3.72 million.
Over the past 12 months, ETF Series Solutions - Loncar China BioPharma ETF recorded a return of 0.00%, with its price trading between $0.00 and $0.00 during the same period.
The ETF is traded under the ticker CHNA.
The current price of CHNA is $0.00. You can track the real-time price chart, review historical performance, and access detailed information about this ETF on the platform.
CHNA is currently trading at $0.00, with a market capitalization of approximately $3.720.524,00. Over the past year, the ETF has delivered a 0.00% return, based on share price performance.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
You can invest in CHNA through a brokerage account that provides access to the exchange where it is listed. After opening and funding your account, search for the ticker symbol CHNA, select the number of shares you wish to purchase, and place your order.
In certain markets, similar exposure may also be available through locally listed products that track the same index.
Over the past month, CHNA has returned 0.00%, and 0.00% over the past year.
If you were to purchase 100 shares of CHNA at the current price of $0.00, your total investment would be $0.00.
Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.
Sign in with your social account or email
Create your account
Already have an account? Login
Tesla
Dividend Schedule
Ranking of Stocks
Ranking of Brazilian ETFs
Crypto Rankings
